modified vaccinia ankara hiv vaccine

Vaccineexperimental

Clinical trial activity

3 trials · 11 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2005 (NCT00252148)

Timeline

2000s

  1. Jan 1, 2005

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • modified vaccinia ankara hiv vaccine
  • modified vaccinia virus ankara (mva) hiv-1 vaccines
  • vaccinia ankara

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01881581Phase 1Jun 1, 2013Capital Medical University, Centers for Disease Control and Prevention, China, Chinese Academy of Medical Sciences, Government of China
NCT01461447Phase 1/Phase 2 (Phase 2)Mar 1, 2012Karolinska Institute, Muhimbili University, Swedish Institute for Infectious Disease Control, United States Army
NCT00252148Phase 1Jan 1, 2005International AIDS Vaccine Initiative, Rockefeller University, University of Rochester
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (11)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Capital Medical UniversityAcademic/Hospital1012013
Centers for Disease Control and Prevention, ChinaGovernment1112013
Chinese Academy of Medical SciencesAcademic/Hospital1012013
Government of ChinaGovernment1012013
International AIDS Vaccine InitiativeAcademic/Hospital1112005
Karolinska InstituteAcademic/Hospital1012012
Muhimbili UniversityAcademic/Hospital1112012
Rockefeller UniversityAcademic/Hospital1012005
Swedish Institute for Infectious Disease ControlGovernment1012012
United States ArmyGovernment1012012
University of RochesterAcademic/Hospital1012005
11 organizations
Page 1 / 1